{"_id": "64ff8e278ed67004cfc73a88", "nctID": "NCT02862275", "Not yet fixed MQL": "{\n\"and\": [\n{\n\"$and\": [\n{\n\"$or\": [\n{\"histologically confirmed malignancy\"},\n{\"pathologically confirmed malignancy\"}\n]\n},\n{\n\"$or\": [\n{\"metastatic malignancy\"},\n{\"unresectable malignancy\"}\n]\n},\n{\n\"$not\": {\n\"$or\": [\n{\"standard of care therapy exists\": true},\n{\"standard of care therapy is effective\": true}\n]\n}\n}\n]\n},\n{\n\"$and\": [\n{\"ACT infusion prior to study enrollment\": true},\n{\n\"$or\": [\n{\"ACT with tumor infiltrating lymphocytes (TIL)\": true},\n{\"human leukocyte antigen (HLA)-class I T cell receptor (TCR)-engineered lymphocytes\": true},\n{\"HLA-class II TCR-engineered lymphocytes\": true},\n{\"chimeric antigen receptor (CAR)-engineered T cells\": true}\n]\n}\n]\n},\n{\n\"$and\": [\n{\"prior ACT therapy completed\": true},\n{\n\"$or\": [\n{\"radiographic progression of disease\": true},\n{\"active disease observed on biopsy\": true},\n{\n\"$and\": [\n{\"pre-treatment biopsy demonstrating viable tumor cells\": true},\n{\"clinical progression of disease\": true}\n]\n}\n]\n}\n]\n},\n{\n\"$and\": [\n{\"solid tumor patients have measurable disease\": true},\n{\n\"$or\": [\n{\"prior systemic therapy\": true},\n{\"prior radiation therapy\": true},\n{\"prior surgery\": true}\n]\n}\n]\n}\n]\n}"}